LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Global Cryoablation Devices Market

Published July 2020 | 10 Pages | 14 Exhibits | Forecasts Through 2024


Order individually or subscribe and get a complete intel platform.


This report from Life Science Intelligence provides the latest market data for the Global Cryoablation Devices Market. Information covered by this report includes:

  • unit volumes & pricing forecast from 2019-2024
  • analyses of the leading companies, and
  • global market share analysis

The global market for cryoablation devices was valued at an estimated $183 million in 2020 and is projected to increase at a CAGR (2020-2024) of 12.6%..

This report covers the impact of COVID-19 on the cryoablation devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Boston Scientific, Endocare, Medtronic, and others. The report provides insights into trends, drivers, and limiters of the cryoablation devices market, as well as highlights potential opportunities.

Cryoablation procedures were negatively impacted by the COVID-19 pandemic. The pandemic has had a substantial impact on elective surgical procedures as healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients. 

Boston Scientific is the market leader of the global cryoablation devices market. The company acquired BTG in 2019, which resulted in the company gaining its market-leading position.

Companies Covered

  • Boston Scientific BTG
  • Brymil Cryogenica
  • CooperSurgical/Wallach Surgical
  • Cryoconcepts
  • Cryoprobe
  • CryoSurgery Inc.
  • Endocare
  • Erbe
  • Grand Cryo LLC
  • KryoLife
  • Medtronic Medical
Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.